Retesting Ibutamoren: following up on last cycle's discrepancies
Purity across our Ibutamoren samples ranged from 96.9% to 96.9%. Here is the context.
The Peptide Institute Testing Desk··14 min read
Ibutamoren is a non-peptide ghrelin receptor agonist with a development status of "discontinued clinical development". The Institute rates the strength of its published evidence as moderate. An orally active, non-peptide growth hormone secretagogue. It is not a peptide, but it is sold and discussed alongside them.
This report covers the Ibutamoren samples processed in our most recent testing cycle. Every specimen was purchased anonymously at retail, transferred under chain-of-custody documentation, and analysed by an independent contract laboratory.
The Institute has independently tested 1 Ibutamoren sample from 1 company. 100% met their label claims on purity and content. Measured purity ranged from 96.9% to 96.9%, averaging 96.9%. Every specimen is published in full, including the laboratory that ran it.
The Peptide Institute is an independent research institute. We do not sell products, we do not accept vendor sponsorship, and we publish results that reflect badly on companies as readily as results that do not.
23 samples, 12 sellers, one compound with almost no human evidence behind it. Measured purity ranged from 61% to 98.9%.
Institute Investigation
Free download
Get the free Peptide Playbook, plus new breakthroughs as they happen.
What peptides are, why people are using them, and what results people are talking about,
in plain English. Sign up and we email you the Playbook right away.
